IRIS
SOLLA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.496
AS - Asia 4.059
SA - Sud America 2.922
EU - Europa 1.320
AF - Africa 196
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 15.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.321
BR - Brasile 2.555
SG - Singapore 1.875
CN - Cina 646
VN - Vietnam 545
HK - Hong Kong 363
IT - Italia 258
FR - Francia 223
DE - Germania 211
AR - Argentina 143
UA - Ucraina 125
FI - Finlandia 103
GB - Regno Unito 93
CA - Canada 77
IN - India 74
RU - Federazione Russa 73
BD - Bangladesh 71
TR - Turchia 64
MX - Messico 61
ZA - Sudafrica 60
EC - Ecuador 58
IQ - Iraq 56
ID - Indonesia 50
VE - Venezuela 44
UZ - Uzbekistan 42
MA - Marocco 41
PK - Pakistan 36
CO - Colombia 32
JP - Giappone 31
NL - Olanda 28
ES - Italia 27
PL - Polonia 26
PY - Paraguay 26
TN - Tunisia 25
AE - Emirati Arabi Uniti 23
AT - Austria 23
PE - Perù 23
KE - Kenya 21
SE - Svezia 20
AZ - Azerbaigian 18
CZ - Repubblica Ceca 18
MY - Malesia 18
JO - Giordania 17
EG - Egitto 16
NP - Nepal 16
TH - Thailandia 16
PH - Filippine 15
UY - Uruguay 15
BE - Belgio 14
CL - Cile 14
LT - Lituania 13
DZ - Algeria 11
CR - Costa Rica 10
AU - Australia 9
BO - Bolivia 9
EU - Europa 9
OM - Oman 9
IE - Irlanda 8
SA - Arabia Saudita 8
GR - Grecia 7
JM - Giamaica 7
KG - Kirghizistan 7
LB - Libano 7
AL - Albania 6
IL - Israele 6
KR - Corea 6
PS - Palestinian Territory 6
RS - Serbia 6
BY - Bielorussia 5
HN - Honduras 5
KZ - Kazakistan 5
RO - Romania 5
SN - Senegal 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BN - Brunei Darussalam 4
DO - Repubblica Dominicana 4
GE - Georgia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
HU - Ungheria 3
LU - Lussemburgo 3
PA - Panama 3
EE - Estonia 2
GY - Guiana 2
IR - Iran 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ME - Montenegro 2
MN - Mongolia 2
NG - Nigeria 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 14.993
Salva come PNG Salva come JPEG
Città #
Dallas 3.066
Singapore 931
San Jose 567
Chandler 513
Hong Kong 357
Ashburn 344
Princeton 222
Ho Chi Minh City 189
Beijing 188
Lauterbourg 161
São Paulo 159
Hanoi 126
Shanghai 109
Los Angeles 93
Rio de Janeiro 83
Helsinki 80
Santa Clara 77
Belo Horizonte 73
New York 72
Munich 55
Brasília 53
Wilmington 46
Jacksonville 40
Frankfurt am Main 39
Johannesburg 39
Tashkent 38
Porto Alegre 36
The Dalles 36
Campinas 35
Orem 33
Columbus 31
Rome 30
Tokyo 29
Cagliari 27
Curitiba 27
Da Nang 27
Jakarta 26
Brooklyn 25
Guarulhos 25
Haiphong 25
Montreal 25
Quito 25
Toronto 25
Denver 24
Nuremberg 24
Salvador 24
Baghdad 23
Buenos Aires 23
Atlanta 22
Chennai 22
Falls Church 22
Mexico City 21
Warsaw 21
Council Bluffs 19
London 19
Lima 18
Amman 17
Campo Grande 17
Düsseldorf 17
Recife 17
Baku 16
Fortaleza 16
Franca 16
Juiz de Fora 16
Nairobi 16
Poplar 16
Ribeirão Preto 16
San Francisco 16
Tianjin 16
Amsterdam 15
Bangkok 15
Contagem 15
Dhaka 15
Manaus 15
Turku 15
Asunción 14
Betim 14
Guayaquil 14
Manchester 14
Santo André 14
Sassari 14
Sorocaba 14
Stockholm 14
Falkenstein 13
Florianópolis 13
Guangzhou 13
Istanbul 13
Mauá 13
São José do Rio Preto 13
Tunis 13
Uberlândia 13
Boston 12
Brussels 12
Cape Town 12
Caracas 12
Chicago 12
Houston 12
Lahore 12
Limeira 12
Milan 12
Totale 9.115
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 337
Teaching Video NeuroImage: The "Chameleon Eyes Sign" in Myasthenia Gravis 201
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 192
Herv-k modulates the immune response in als patients 179
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 173
The natural history of body-first versus brain-first Parkinson's disease subtypes 162
Adapted physical activity on motor and non-motor symptoms, and quality of life in Parkinson's disease patients 154
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 153
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 150
An Ancient Tradition, A New Kind Of Physical Activity: The Sardinian Folk Dance ‘Ballu Sardu’ 150
Diagnostic Value of the "Insular Knife-Cut" Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 149
Body weight-supported high-intensity locomotor training and adapted physical activity program in patients with Parkinson's disease: a complementary approach? 145
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 145
Early discontinuation and titration strategies in foslevodopa/foscarbidopa therapy for Parkinson's disease 143
Bipolar affective disorder and Parkinson's disease: A rare, insidious and often unrecognized association 138
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI 138
Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease 136
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 136
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 135
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 135
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 133
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 133
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 132
Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 130
Alternating or metronome pisa syndrome in patients under drugs acting on dopaminergic pathways 129
C9ORF72 Intermediate Repeat Expansion in a Patient with Psychiatric Disorders and Progressive Cerebellar Ataxia 129
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 127
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment [2] 127
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: Drug effects of withania somnifera (Dunal) administration 123
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 123
Autoimmune encephalitis misdiagnosis and mimics 119
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 116
Exposure to TNF inhibitors is rare at MOGAD presentation 112
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 110
VGF peptides as novel biomarkers in Parkinson’s disease 108
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 107
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 106
Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD 104
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 104
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients 102
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 101
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease 101
Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 100
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 100
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 100
Pisa-like syndrome under Baclofen in a patient with spastic hemiparesis due to ischemic stroke 99
Pisa syndrome in a patient with pathologically confirmed Parkinson's disease 99
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non-tremor-dominant subtypes really uncorrelated to olfactory impairment? 98
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 97
Land- and water-based sports activities in natural environments as a group exercise for Parkinson’s disease: proof-of-concept pilot study 96
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 95
Seasonal variation in myasthenia gravis incidence 95
Fluctuating off-period hemidystonia with Pisa syndrome in advanced Parkinson's disease 94
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 93
Neurological and Psychiatric Disorders in the COVID-19 Era 93
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 93
Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature 93
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells 92
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 92
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 92
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 92
Capgras syndrome in Parkinson’s disease: two new cases and literature review 92
Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease 92
Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease 90
Delusional jealousy in Parkinson's disease patients with and without dementia 90
A new national survey of centers for cognitive disorders and dementias in Italy 89
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data 89
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 88
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 88
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 88
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review 87
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 87
Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia 87
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases 86
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations 86
Neuroimaging evaluations of olfactory, gustatory, and neurological deficits in patients with long-term sequelae of COVID-19 86
Nonconvulsive status epilepticus as onset of Creutzfeldt-Jakob disease 85
Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease 85
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with parkinson’s disease 85
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 84
Olfactory hallucinations in Parkinson's disease patients and the role of their evaluation in clinical practice 84
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 84
Internal carotid artery dissection causing ischemic stroke during pole sport practice 84
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 84
Nordic Walking for the Management of People With Parkinson Disease: A Systematic Review 84
Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 84
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 83
Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination 83
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease 82
Network analysis of gut microbial communities reveal key genera for a multiple sclerosis cohort with Mycobacterium avium subspecies paratuberculosis infection 81
Dopamine agonist withdrawal syndrome in Parkinson's disease 81
Risk factors of Parkinson disease Simultaneous assessment, interactions, and etiologic subtypes 80
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson’s disease 79
Corrigendum to [123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism [Schizophr. Res. 113 (2009) 41-48] 78
Functional neurological disorders and Parkinson's disease – A new research agenda? 77
Olfactory Impairment in Parkinson’s Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study 77
Relationship between risk and protective factors and clinical features of Parkinson's disease 77
Neurological Consequences of COVID-19: A Systematic Review of the Pandemic’s Impact on Neurology Training 76
Frequency and determinants of olfactory hallucinations in parkinson’s disease patients 76
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia 76
Totale 10.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022434 14 2 0 10 11 14 6 27 18 22 99 211
2022/20231.000 120 74 58 149 76 173 3 99 171 13 40 24
2023/2024335 55 28 7 6 47 5 6 38 4 3 40 96
2024/20254.727 76 59 279 99 155 137 227 985 1.726 668 186 130
2025/20268.474 250 1.728 2.012 1.438 883 386 804 236 330 314 93 0
Totale 15.231